Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 3/2004

01-05-2004 | Invited update

Crohn disease: magnetic resonance enteroclysis

Authors: G. Masselli, M. G. Brizi, A. Parrella, M. L. Minordi, A. Vecchioli, P. Marano

Published in: Abdominal Radiology | Issue 3/2004

Login to get access

Excerpt

Crohn disease is a chronic, inflammatory transmural disease of any part of the gastrointestinal (GI) tract that commonly involves the small bowel, in particular the terminal ileum. In the United States and northern Europe, Crohn disease is the most common small bowel disease, with an incidence of seven in 100,000; it is infrequent in Asia (Japan excluded) and in Central and South America, with an incidence of 0.08 in 100,000 [1]. …
Literature
1.
Sandler, RS, Golden, AL 1986Epidemiology of Crohn’s disease.J Clin Gastroenterol8160165PubMed
2.
Przemioslo, RT, Ciclitira, PJ 1995Pathogenesis of Crohn’s disease.Q J Med88525527
3.
Chernish, SM, Maglinte, DDT, O’ Connor, K 1992Evaluation of small intestine by enteroclysis for Crohn’s disease.Am J Gastroenterol87696701PubMed
4.
Herlinger, H 1982The small bowel enema and the diagnosis of Crohn’s disease.Radiol Clin North Am20721742PubMed
5.
Yao, T, Okada, M, Fuchigami, T,  et al. 1989The relationship between the radiological and clinical features in patients with Crohn’s disease.Clin Radiol40389392PubMed
6.
Bender, GN, Timmons, JH, Williard, WC,  et al. 1996Computed tomographic enteroclysis: one methodology.Invest Radiol314349CrossRefPubMed
7.
Prassopoulos, P, Papanikolau, N, Grammatikakis, J,  et al. 2001MR enteroclysis imaging of Crohn disease.Radiographics21161172PubMed
8.
Gourtsoyiannis, N, Papanikolaou, N, Grammatikakis, J, Prassopoulos, P 2002MR enteroclysis: technical considerations and clinical applications.Eur Radiol1226512658PubMed
9.
Umschaden, HW, Szolar, D, Gasser, J,  et al. 2000Small bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings.Radiology215717725PubMed
10.
Rieber, A, Aschoff, A, Nussle, K,  et al. 2000MRI in diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis.Eur Radiol1013771382CrossRefPubMed
11.
Minowa, O, Ozaki, Y, Kyogoku, S,  et al. 1999MR imaging of the small bowel using water as a contrast agent in a preliminary study with healthy volunteers.AJR173581582PubMed
12.
Anderson, CM, Brown, JJ, Balfe, DM,  et al. 1994MR imaging of Crohn’s disease: use of Perflubron as a gastrointestinal contrast agent.J Magn Reson Imaging4491496PubMed
13.
Mitchell, DG, Vinitski, S, Mohamed, FD,  et al. 1991Comparison of Kaopectate with barium for negative and positive enteric contrast at MR imaging.Radiology181475480PubMed
14.
Gourtsoyiannis, N, Papanikolau, N, Grammatikakis, J,  et al. 2000Magnetic resonance imaging of the small bowel using true-FISP sequence after enteroclysis with water solution.Invest Radiol35707711CrossRefPubMed
15.
Gourtsoyiannis, N, Papanikolau, N, Grammatikakis, J,  et al. 2001MR enteroclysis protocol optimization: comparison between 3d FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences.Eur Radiol11908913CrossRefPubMed
16.
Lee, JK, Marcos, HB, Semelka, RC 1998MR Imaging of the small bowel using the HASTE sequence.AJR17014571463PubMed
17.
Shoenunt, JP, Semelka, RC, Silverman, R,  et al. 1994Magnetic resonance imaging in inflammatory bowel disease: demonstration by MRI.J Clin Gastroenterol193135PubMed
18.
Laufer, I, Costopoulos, L 1978Early lesions of Crohn’s disease.AJR130307311PubMed
19.
Umschaden, HW, Gasser, J 2003MR enteroclysis.Radiol Clin North Am41231248PubMed
20.
Meyers, MA, McGuire, PV 1995Spiral CT demonstration of hypervascularity in Crohn disease: “vascular jejunalization of the ileum” or the “comb sign.”Abdom Imaging20327332PubMed
21.
Przemioslo, RT, Ciclitira, PJ 1995Pathogenesis of Crohn’s disease.Q J Med88525527
22.
Bell, S, Kamm, MA 2000Antibodies to tumour necrosis factor as a treatment for Crohn’s disease.Lancet335858859CrossRef
23.
Best, WR, Becktel, JM, Singleton, JW,  et al. 1979Rederived values of the eight coefficients of the Crohn’s Disease Activity Index (CDAI).Gastroenterology77843846PubMed
24.
Hanaouer, SB 1994Measurements of disease activity.Targan, SRShanan, F eds. Inflammatory bowel disease: from bench to bedside.Williams & WilkinsBaltimore429444
25.
Yao, T, Okada, M, Fuchigami, T,  et al. 1989The relationship between the radiological and clinical features in patients with Crohn’s disease.Clin Radiol40389392PubMed
26.
Maglinte, DT, Gourtsoyannis, N, Rex, D,  et al. 2003Classification of small bowel Crohn’s subtypes based on multimodality imaging.Radiol Clin North Am41285303PubMed
27.
Koh, DM, Miao, Y, Chinn, RJS,  et al. 2001MR imaging evaluation of the activity of Crohn’s disease.AJR17713251332PubMed
28.
Madsen, SM, Thomsen, HS, Schlichting, P,  et al. 1999Evaluation of treatment response in active Crohn’s disease by low field magnetic resonance imaging.Abdom Imaging24232239CrossRefPubMed
29.
Maccioni, F, Viscido, A, Broglia, L,  et al. 2000Evaluation of Crohn disease activity with magnetic resonance imaging.Abdom Imaging25219238CrossRefPubMed
30.
Gore, RM, Balthazar, EJ, Ghahremani, GG, Miller, FH 1996CT features of ulcerative colitis and Crohn’s disease.AJR167315PubMed
31.
Lee, SS, Ha, HK, Yang, SK 2002CT of prominent pericolic or perienteric vasculature in patients with Crohn’s disease: correlation with clinical disease activity and findings on barium studies.AJR17910291036PubMed
32.
Schwerk, WB, Beck, K, Raith, M,  et al. 1992A prospective evaluation of high resolution sonography in the differential diagnosis of inflammatory bowel disease.Eur J Gastroenterol Hepatol4173182
Metadata
Title
Crohn disease: magnetic resonance enteroclysis
Authors
G. Masselli
M. G. Brizi
A. Parrella
M. L. Minordi
A. Vecchioli
P. Marano
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2004
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-003-0116-9

Other articles of this Issue 3/2004

Abdominal Radiology 3/2004 Go to the issue

Publisher’s Note

New and forthcoming electronic features for Abdominal Imaging

Original article

PET-CT detection of abdominal recurrence of ovarian cancer: radiologic–surgical correlation

Invited update

Focal liver lesions: evaluation with contrast-enhanced ultrasonography

Original article

Metanephric adenoma of the kidney

Invited update

Radiologic evaluation in planning surgery of renal tumors

Original aritcle

Vesicoureteral reflux in young patients: Comparison of voiding color Doppler US with echo enhancement versus voiding cystourethrography for diagnosis or exclusion
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits